CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 110 participants.
Also called NCT07351643
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 110 participants
- Sponsor
- Registry
-
NCT07351643
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07351643. Randomized; no masking; primary purpose treatment. Start 2026-06-25 (actual); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CCTA Evaluation of SGLT2i-related Pericoronary Fat Changes Patients With Stage 4 CKM Syndrome
- Acronym
- DAPA-PCAT
- Condition
- ACS (Acute Coronary Syndrome)
- Condition
- SGLT2 Inhibitors
- Intervention (Drug)
- Dapagliflozin
- Lead sponsor
- Shenyang Northern Hospital
Record details
- Record id
cardio:ct-nct07351643- Content hash
35c00fd60f4bc49ef7cea5a3dd901aa3bf7bafd466c8dc997f936ae6bfdf8747